Skip to main content
NIH funding notice RFA-AR-18-002

Mechanistic Ancillary Studies to Ongoing Interventional Clinical Trials (R01)

Closed on April 2, 2018.

Posted
May 1, 2017
Close date
April 2, 2018
Activity codes
Not stated on the notice page
Institutes taking part
Not stated on the notice page

Read the notice on Grants.gov · NIH Guide page

The notices it replaced

Its page was not saved, so the notices it replaced are not known.

Who won it before

3 competing awards (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $1,265,062 in first-year total cost, median $402,447.

Most frequent study sections

  1. Special Emphasis Panel[ZAR1 XZ (M2)]2
  2. Special Emphasis Panel[ZAR1 YL (M1)]1

Most frequent institutions

  1. BRIGHAM AND WOMEN'S HOSPITAL1
  2. UNIVERSITY OF CALIFORNIA, SAN FRANCISCO1
  3. WASHINGTON UNIVERSITY1
Competing awards under RFA-AR-18-002 and the notices it replaced
FYProjectPIsInstitutionFirst-year costStudy section
2018Reversing immune evasion and enhancing immune detection with topical resiquimod1R01AR074797-01CLARK, RACHAEL ANNROOK, ALAIN HBRIGHAM AND WOMEN'S HOSPITAL, MA$513,783ZAR1
2018Genetic Factors of Bone Loss in Older Adults Taking Antidepressants1R01AR073017-01A1PETERSON, TIMOTHY RWASHINGTON UNIVERSITY, MO$402,447ZAR1
2018Pharmacologic modulation of innate immune dysfunction in heterotopic ossification1R01AR073015-01A1HSIAO, EDWARD CUNIVERSITY OF CALIFORNIA, SAN FRANCISCO, CA$348,832ZAR1

Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-10-0.1.1. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.

ScienceDex for faculty

Your academic CV and NIH biosketch

Make your CV in your school's format and your NIH biosketch from it, then download both as Word files.

RFA-AR-18-002: Mechanistic Ancillary Studies to Ongoing Interventional Clinical Trials (R01) | ScienceDex | ConductScience